WDR5 WIN site inhibitor C3
CAS No. ——
WDR5 WIN site inhibitor C3( —— )
Catalog No. M17064 CAS No. ——
WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWDR5 WIN site inhibitor C3
-
NoteResearch use only, not for human use.
-
Brief DescriptionWDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.
-
DescriptionWDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM; inhibits leukemia cell lines in vitro (MV4:11 cell GI50=6.67 uM), rapidly displace WDR5 from chromatin and decrease the expression of associated genes, causing translational inhibition, nucleolar stress, and p53 induction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight386.427
-
Molecular FormulaC20H23FN4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name3-(((4,5-dihydro-1H-imidazol-2-yl)amino)methyl)-N-(3,5-dimethoxybenzyl)-4-fluorobenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aho ER, et al. Cell Rep. 2019 Mar 12;26(11):2916-2928.e13.
molnova catalog
related products
-
BIX-01294
A specific small molecule G9a histone methyltransferase inhibitor with IC50 of 1.7 uM.
-
TP-064
TP-064 is a potent, selective, and cell-active inhibitor of PRMT4 with IC50 of <10 nM and Kd of 7.1 nM.
-
EZM 2302
EZM 2302 (EZM2302, GSK 3359088)?is a potent, selective, orally available arginine methyltransferase CARM1 inhibitor with IC50 of 6 nM.
Cart
sales@molnova.com